Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Nuvo Pharmaceuticals Inc MRVFF

Healthcare Drug Manufacturers - Specialty & Generic
Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. see more

Bullboard (OTCQX:MRVFF)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next
Comment by lscfaon Nov 01, 2019 5:26pm

RE:RE:WHY the sell off

Investors are getting confused with distorted accounting no.s and distorted cash flow no.s. Must rely on adj ebitda no.s......       Q3  ...more  
157
Discussion
Comment by ValueCapon Nov 01, 2019 5:25pm

RE:RE:WHY the sell off

I agree! Operating income was much higher, owing in part to GA and marketing down from synergies. Even ex vimovo US the company is in a decent position  Nothing changed since yesterday, then ...more  
151
Discussion
Comment by lscfaon Nov 01, 2019 4:56pm

RE:WHY the sell off

I think people are looking at the net income line and seeing that Q3 is down from Q2 but Q2 had a bunch of one-time non-cash items. Co. should change its presentation and show an operating income line ...more  
147
Discussion
Comment by midardon Nov 01, 2019 4:38pm

RE:Undervalued

Market cap 3.7M, yesterday earning 4.4M ridiculous
109
Discussion
Post by lscfaon Nov 01, 2019 3:57pm

Undervalued

Stock screeners show the last 12 months eps as a loss of $0.07 but this will change with next qtr.....
165
Discussion
Comment by lscfaon Nov 01, 2019 3:09pm

RE:RE:RE:Market cap only 5.3M

ebitda for the qtr was $7.8 mil with $1.7 mil from Vimovo USA.     If you exclude Vimovo USA ebitda = $6.1 mil/qtr (or $24 mil per yr)     EV/ebitda = 6x which is cheap ...more  
129
Discussion
Post by midardon Nov 01, 2019 2:54pm

WHY the sell off

Market cap was almost the same as earning yesterday. who is anonimous?
186
Discussion
Post by ValueCapon Oct 31, 2019 10:10pm

Vimovo Royalty Possibly Staying Until mid to late 2021?

Yes, the earnings were great as noted. They executed on the synergies - SG&A way down from q2. On target to achieve the 7 million/ year savings as noted in June. A win for the company. Excluding ...more  
157
Comment by lscfaon Oct 31, 2019 10:46am

RE:RE:Market cap only 5.3M

correction: enterprise value = $148.2 million.    The $126 million debt shown on the balance sheet is a carrying value.     The principal o/s is $161.7 million.  
147
Discussion
Comment by lscfaon Oct 31, 2019 9:37am

RE:Market cap only 5.3M

But enterprise value = $112 million.     debt... $126 mil.     cash...$18 mil.    mkt cap...$4.5 mil.      
120
Discussion
Post by midardon Oct 31, 2019 7:43am

Market cap only 5.3M

· Third Quarter Adjusted Total Revenue - $18.9 million and $55.1 million year-to-date · · Third Quarter Adjusted EBITDA - $7.8 million and $18.7 million year-to-date  ...more  
211
Discussion
Post by ValueCapon Oct 24, 2019 9:52am

Vimovo US Royalty to stay at least a little while longer...

Dr Reddy’s didn’t launch ‘at risk’ by October 20. The royalty for Q4 is likely still in tact. Ongoing litigation continues for the other patents. Timeline to be revealed in the coming months.  ...more  
238
Post by JoeClemens53on Oct 17, 2019 8:37am

Nuvo Key Date

ICYM l https://cutt.ly/jedhlgO
192
Post by runmyownlifeon Sep 13, 2019 5:45pm

New York presentation

Should have used the money spent on the trip to pay down debt.
257
Post by consultant99on Sep 11, 2019 2:08pm

Down down .... down

New 52 week low (probably an all-time low) at 0.47/share LESS THAN HALF THE PRICE OF CTX! in what warped universe does anyone associated with this company still have a job that pays them money ...more  
326
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities